Arezoo Asadi
Impact in
- Biotechnology top 5%
- Cancer Research and Treatments
- Food Science top 5%
- Probiotics and Fermented Foods
Papers in
-
- COVID-19 Clinical Research Studies 3
- Antimicrobial Resistance in Staphylococcus 3
-
- Gut microbiota and health 6
- Co-authors
- Malihe Talebi (8 shared papers)Mohsen Heidary (11 shared papers)Elnaz Ohadi (3 shared papers)Saeed Khoshnood (5 shared papers)Roya Ghanavati (9 shared papers)Atieh Darbandi (8 shared papers)Amir Darb Emamie (2 shared papers)Maryam Kakanj (2 shared papers)
- Journals
- Journal of Clinical Laboratory Analysis (4 papers)Microbial Pathogenesis (2 papers)Diagnostic Microbiology and Infectious Disease (2 papers)Infection (2 papers)Biomedicine & Pharmacotherapy (2 papers)
- Partner nations
- IranUnited StatesItaly
In The Last Decade
Arezoo Asadi
30 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 120
- Biotechnology 176
- Food Science 264
- Molecular Medicine 72
- Microbiology 85
- Infectious Diseases 224
Countries citing papers authored by Arezoo Asadi
This map shows the geographic impact of Arezoo Asadi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arezoo Asadi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arezoo Asadi more than expected).
Fields of papers citing papers by Arezoo Asadi
This network shows the impact of papers produced by Arezoo Asadi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arezoo Asadi. The network helps show where Arezoo Asadi may publish in the future.
Co-authors
The 25 scholars most cited alongside Arezoo Asadi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Bacteriocins: Properties and potential use as antimicrobials Hit paper breakdown → | 2021 | 270 |
| 2 | 2019 | 205 | |
| 3 | 2022 | 127 | |
| 4 | 2018 | 104 | |
| 5 | 2018 | 96 | |
| 6 | 2020 | 63 | |
| 7 | 2018 | 56 | |
| 8 | 2023 | 49 | |
| 9 | 2021 | 36 | |
| 10 | 2022 | 30 | |
| 11 | 2021 | 20 | |
| 12 | 2020 | 18 | |
| 13 | 2019 | 17 | |
| 14 | 2022 | 15 | |
| 15 | 2022 | 14 | |
| 16 | The diversity of class B and class D carbapenemases in clinical Acinetobacter baumannii isolates. | 2018 | 12 |
| 17 | 2022 | 10 | |
| 18 | 2020 | 8 | |
| 19 | 2022 | 6 | |
| 20 | 2018 | 6 |
About Arezoo Asadi
Arezoo Asadi is a scholar working on Infectious Diseases, Molecular Biology, Epidemiology, Molecular Medicine and Food Science, having authored 33 papers that have together received 1.2k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (6 papers), Gut microbiota and health (6 papers), Probiotics and Fermented Foods (5 papers), Pneumonia and Respiratory Infections (3 papers), COVID-19 Clinical Research Studies (3 papers), Antimicrobial Resistance in Staphylococcus (3 papers), Pneumocystis jirovecii pneumonia detection and treatment (2 papers) and Hepatitis B Virus Studies (2 papers). The work is most often cited by research in Biotechnology (176 citations), Food Science (264 citations), Molecular Medicine (72 citations), Microbiology (85 citations) and Infectious Diseases (224 citations). Arezoo Asadi has collaborated with scholars based in Iran, United States and Italy. Frequent co-authors include Malihe Talebi, Mohsen Heidary, Elnaz Ohadi, Saeed Khoshnood, Roya Ghanavati, Atieh Darbandi, Amir Darb Emamie, Maryam Kakanj, Mehrdad Gholami and Marzie Mahdizade Ari. Their work appears in journals such as Journal of Clinical Laboratory Analysis, Microbial Pathogenesis, Diagnostic Microbiology and Infectious Disease, Infection and Biomedicine & Pharmacotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.